Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSFORM: Setanaxib in PBC
NCT05014672Phase 2Completed
- Sponsor
- Calliditas Therapeutics AB
- Start
- Feb 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of setanaxib in primary biliary cholangitis (PBC), sponsored by Calliditas Therapeutics AB. Started Feb 2022; status: completed.
02
Drugs
setanaxib
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT05014672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05014672.